Drug intelligence / Profile preview

royal jelly + panthenol

Development stage
Phase 3
Lead developer
European Egyptian Pharmaceutical Industries
Modality
Small Molecules
Administration
Topical
01

Overview

Royal jelly + panthenol (marketed under the brand name Pedyphar) is a topical combination therapy developed by European Egyptian Pharmaceutical Industries for the treatment of diabetic foot ulcers. Royal jelly is a complex biological substance secreted by honey bees that contains bioactive proteins (Major Royal Jelly Proteins) and fatty acids (such as 10-hydroxy-2-decenoic acid) which exhibit antimicrobial, anti-inflammatory, and regenerative properties. These components stimulate fibroblast migration and collagen synthesis, essential for wound closure. Panthenol, a provitamin of B5, acts as a humectant and is converted in the skin to pantothenic acid, a precursor of coenzyme A. This metabolic pathway supports epithelialization and the maintenance of the skin barrier. The combination is formulated as an ointment to provide a protective environment that accelerates the healing of chronic diabetic wounds.

Brand names
Pedyphar
Other names
royal jelly + panthenol ointmentPedyphar Ointment
02

Targets

PANK (Pantothenate kinase)

Beyond the preview

Go deeper on royal jelly + panthenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on royal jelly + panthenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call